Innovation Pharmaceuticals Inc (IPIX)

[Orion Nebula]

This article takes a look at a pet peeve of many: the byzantine clinical trials process. I am gratified the FDA is looking at this. Anyone who was here through the endless Kevetrin trial can appreciate that something needs to change.

There are some interesting ideas presented here although in very rudimentary form. I hope the effort to reform the process continues and results in meaningful change.

https://www.clinicalleader.com/doc/regulatory-science-clinical-research-where-do-we-stand-and-where-are-we-going-0001